ECM
CVAC

ExodusPoint Capital Management’s CureVac CVAC Stock Holding History

ExodusPoint Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,000
Closed -$1.62M – 2187
2020
Q4 		$1.62M Buy
+20,000
New +$1.53M 0.02% 629

Other funds holding CVAC

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

ExodusPoint Capital Management's CVAC Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of CureVac (CVAC) in Q2 2025, closing a stake of 49,554 shares — an estimated $137K sold.

ExodusPoint Capital Management first reported a position in CVAC in Q4 2020 and held it in 9 quarters. The position peaked at $1.39M in Q3 2021. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 49,554 CureVac shares in Q2 2025, an estimated $137K.
  • ExodusPoint Capital Management first reported a position in CureVac in Q4 2020 and held it in 9 quarters.
  • ExodusPoint Capital Management's CureVac position peaked at $1.39M in Q3 2021.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.